| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |